Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAXF7M7z-8nS0oIaT5YC4KNePSREj-dPGKFPlq_U7TTQQ#assertion>. }
Showing items 1 to 15 of
15
with 100 items per page.
- HP_0000709 type Disease assertion.
- association type Statement assertion.
- context type Cohort assertion.
- DRUGBANK:DB01224 type Drug assertion.
- association label "Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, the first medication approved for management of PDP." assertion.
- association label "Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, the first medication approved for management of PDP." assertion.
- context label "Adults" assertion.
- association object HP_0000709 assertion.
- association predicate treats assertion.
- association subject DRUGBANK:DB01224 assertion.
- association relation OffLabelIndication assertion.
- association publications 30588905 assertion.
- association provided_by NeuroDKG assertion.
- context has_phenotype MONDO_0005180 assertion.
- association has_population_context context assertion.